Seelos Announces Issuance of a New Patent and an Additional No... - 14 September 2020 23:00

NEW YORK, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- - Patents Further Strengthen Global Intellectual Property Portfolio in Psychiatry Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders...

  Merck Advances Oncology Portfolio and Pipeline with New and Lo... - 14 September 2020 08:05

DARMSTADT, Germany, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- - New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO(R)* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer - Overall efficacy data, and analyses of brain metastas...

  Global Fund Partnership Has Saved 38 Million Lives – but COVID... - 14 September 2020 08:01

GENEVA, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. Acc...

  Haoma Medica Announces Plenary Presentation for NaQuinate, a P... - 12 September 2020 07:00

LONDON, September 12, 2020, /PRNewswire-AsiaNet/-- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selecti...

  New MAVENCLAD (R) Data at ACTRIMS-ECTRIMS MSVirtual2020 Meetin... - 11 September 2020 22:00

DARMSTADT, Germany, September 11, 2020, /PRNewswire-AsiaNet/-- In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of...

  Sai Life Sciences expands suite of cellular analysis platforms... - 11 September 2020 13:30

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ AsiaNet/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs)[ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=cambridge-cellular-analysis-platforms], today announced the additi...

  Sai Life Sciences expands suite of cellular analysis platforms... - 11 September 2020 10:00

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire-AsiaNet/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs)[ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=cambridge-cellular-analysis-platforms], today announced the additi...

  Poor home hygiene contributing to antibiotic resistance, warn ... - 11 September 2020 09:01

LONDON, September 11, 2020 /PRNewswire-AsiaNet/ -- - According to the Global Hygiene Council's (GHC) public health experts, following a risk-based approach to home hygiene is essential to help curb the growing threat of antibiotic resistance It is estimated that rates of resistance to commonly-...

  iHerb Announces New Chief Financial Officer - 11 September 2020 07:27

PASADENA, California, Sept. 10, 2020 /PRNewswire-AsiaNet/ -- Global health and beauty e-commerce leader iHerb announced today that Roxanne Agnew has been promoted to be the company's new Chief Financial Officer. Photo - https://mma.prnewswire.com/media/1252307/iHerb_Announces_New_Chief_Financial_Officer....

  Merck Announces Positive Phase II Results for Investigational ... - 10 September 2020 22:00

DARMSTADT, Germany, Sept. 10, 2020 /PRNewswire-AsiaNet/ -- Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F - Phase II study was facilitated by Avillion as part of an innovative co-development model Merck, ...